APAC Fluorescent in Situ Hybridization (FISH) Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Asia-Pacific Fluorescent in Situ Hybridization (FISH) market is projected to register a CAGR of 9.3% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Asia-Pacific Fluorescent in Situ Hybridization (FISH) Market, By Product Type (Consumables, Instrument, and Software), Technology (DNA Fluorescent in Situ Hybridization, RNA Fluorescent in Situ Hybridization, PNA Fluorescent in Situ Hybridization, and Others), Application (Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Other), Usage (Clinical, Research, and Companion Diagnostic), End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceuticals & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, and Others), Distribution Channel (Retail Sales, Direct Tender, Online Sales, and Others), Country (China, Japan, India, Australia, New Zealand, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Taiwan, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Asia-Pacific Fluorescent in Situ Hybridization (FISH) market are:

Growing demand for better quality healthcare for genetic disorders and the rising adoption of personalized medicine

Increasing use of the FISH technique due to the rise in patients with breast cancer and other chronic diseases

Market Players

Some of the major market players operating in the Asia-Pacific Fluorescent in Situ Hybridization (FISH) market are:

Thermo Fisher Scientific Inc.

Bio-Techne

Abbott

Agilent Technologies, Inc.

Merck KGaA

F. Hoffmann-La Roche Ltd

Abnova Corporation

BioGenex

1 INTRODUCTION 68

1.1 OBJECTIVES OF THE STUDY 68
1.2 MARKET DEFINITION 68
1.3 OVERVIEW 68
1.4 CURRENCY AND PRICING 70
1.5 LIMITATIONS 70
1.6 MARKETS COVERED 71

2 MARKET SEGMENTATION 74

2.1 MARKETS COVERED 74
2.2 GEOGRAPHICAL SCOPE 75
2.3 YEARS CONSIDERED FOR THE STUDY 76
2.4 DBMR TRIPOD DATA VALIDATION MODEL 77
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 80
2.6 MULTIVARIATE MODELLING 81
2.7 MARKET APPLICATION COVERAGE GRID 82
2.8 PRODUCT LIFELINE CURVE 83
2.9 DBMR MARKET POSITION GRID 84
2.10 VENDOR SHARE ANALYSIS 86
2.11 SECONDARY SOURCES 87
2.12 ASSUMPTIONS 87

3 EXECUTIVE SUMMARY 88

4 PREMIUM INSIGHTS 91

4.1 PORTER'S FIVE FORCES 92
4.2 PESTEL ANALYSIS 93
4.3 INDUSTRY INSIGHTS 94
4.4 CONCLUSION 95

5 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: REGULATORY FRAMEWORK 96

6 MARKET OVERVIEW 98

6.1 DRIVERS 100
- 6.1.1 GROWING BURDEN OF GENETIC DISORDERS AS WELL AS CANCER 100
- 6.1.2 INNOVATION AND ADVANCEMENTS IN FISH PRODUCTS 100
- 6.1.3 HIGH FUNDING FOR RESEARCH ACTIVITIES 101
- 6.1.4 RISING DEMAND AND USAGE OF FISH TECHNIQUES 101
6.2 RESTRAINTS 102
- 6.2.1 HIGH COST OF FISH TESTING 102
- 6.2.2 LIMITED AVAILABILITY OF SKILLED PROFESSIONALS 102
6.3 OPPORTUNITIES 103
- 6.3.1 RISING PUBLIC AWARENESS ABOUT THE EARLY DETECTION OF GENETIC ABNORMALITIES 103
- 6.3.2 RISE IN DEVELOPMENT OF SPECIFIC BIOMARKERS AND VARIOUS PROBES 103
6.4 CHALLENGES 104
- 6.4.1 STRINGENT GOVERNMENT REGULATIONS FOR THE APPROVAL OF FISH PROBES 104
- 6.4.2 ETHICAL CONCERNS ASSOCIATED WITH FISH TECHNOLOGY 104

7 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE 105

7.1 OVERVIEW 106
7.2 CONSUMABLES 109
- 7.2.1 FISH PROBE 109
  - 7.2.1.1 FISH PROBE, BY PROBE TYPE 110
    - 7.2.1.1.1 CHROMOSOME FISH PROBE 110
    - 7.2.1.1.2 SPLIT FISH PROBES 110
    - 7.2.1.1.3 TRANSLOCATION FISH PROBES 110
    - 7.2.1.1.4 SUBTELOMERE FISH PROBES 110
    - 7.2.1.1.5 PRENATAL FISH PROBES 110
    - 7.2.1.1.6 OTHERS PROBES 111
  - 7.2.1.2 FISH PROBE, BY TECHNOLOGY 111
    - 7.2.1.2.1 FLOW FLUORESCENT IN SITU HYBRIDIZATION 111
    - 7.2.1.2.2 C-ISH 111
    - 7.2.1.2.3 D-ISH 111
    - 7.2.1.2.4 Q- FLUORESCENT IN SITU HYBRIDIZATION 111
    - 7.2.1.2.5 OTHERS 111
  - 7.2.1.3 FISH PROBE, BY TYPE 112
    - 7.2.1.3.1 RNA 112
    - 7.2.1.3.1.1 MRNA 112
    - 7.2.1.3.1.2 MIRNA 112
    - 7.2.1.3.1.3 OTHERS 113
    - 7.2.1.3.2 DNA 113
- 7.2.2 ACCESSORY KITS & REAGENTS 113
  - 7.2.2.1 KITS 113
  - 7.2.2.2 BUFFER 113
  - 7.2.2.3 DYES 113
  - 7.2.2.4 OTHERS 114
7.3 INSTRUMENT 114
- 7.3.1 STANDALONE 115
- 7.3.2 PORTABLE 115
- 7.3.3 HANDHELD 115
7.4 SOFTWARE 115

8 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY 116

8.1 OVERVIEW 117
8.2 RNA FLUORESCENT IN SITU HYBRIDIZATION 120
8.3 DNA FLUORESCENT IN SITU HYBRIDIZATION 121
8.4 PNA FLUORESCENT IN SITU HYBRIDIZATION 122
8.5 OTHERS 123

9 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION 124

9.1 OVERVIEW 125
9.2 CANCER RESEARCH 128
- 9.2.1 CANCER RESEARCH, BY CANCER TYPE 129
  - 9.2.1.1 NON-HEMATOPOETIC MALIGNANCIES (SOLID TUMORS) 129
    - 9.2.1.1.1 BREAST CANCER 129
    - 9.2.1.1.2 LUNG CANCER 129
    - 9.2.1.1.3 MELANOMA 130
    - 9.2.1.1.4 PROSTRATE CANCER 130
    - 9.2.1.1.5 OVARIAN CANCER 130
    - 9.2.1.1.6 OTHERS 130
  - 9.2.1.2 HEMATOPOETIC MALIGNANCIES 130
    - 9.2.1.2.1 LEUKEMIA 130
    - 9.2.1.2.2 MULTIPLE MYELOMA 131
    - 9.2.1.2.3 MYELODYSPLASTIC SYNDROMES (MDS) 131
- 9.2.2 CANCER RESEARCH, BY PRODUCT 131
  - 9.2.2.1 CONSUMABLES 131
  - 9.2.2.2 INSTRUMENTS 131
  - 9.2.2.3 SOFTWARE 131
9.3 GENETIC RESEARCH 132
- 9.3.1 CYTOGENETICS 133
- 9.3.2 CHROMOSOMAL ABNORMALITIES 133
- 9.3.3 OTHERS 133
9.4 INFECTIOUS DISEASE 133
- 9.4.1 CONSUMABLES 134
- 9.4.2 INSTRUMENTS 134
- 9.4.3 SOFTWARE 134
9.5 PERSONALIZED MEDICINE 134
9.6 OTHERS 135

10 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE 136

10.1 OVERVIEW 137
10.2 RESEARCH 140
- 10.2.1 INSTRUMENTS 140
- 10.2.2 CONSUMABLES 141
- 10.2.3 SOFTWARE 141
10.3 CLINICAL 141
- 10.3.1 CONSUMABLES 142
- 10.3.2 INSTRUMENT 142
- 10.3.3 SOFTWARE 142
10.4 COMPANION DIAGNOSTIC 142
- 10.4.1 CONSUMABLES 143
- 10.4.2 INSTRUMENT 143
- 10.4.3 SOFTWARE 143

11 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER 144

11.1 OVERVIEW 145
11.2 DIAGNOSTIC LABORATORIES 148
11.3 HOSPITALS & CLINICS 148
11.4 PHARMACEUTICALS & BIOTECHNOLOGICAL COMPANIES 149
11.5 ACADEMIC & RESEARCH INSTITUTES 150
11.6 CONTRACT RESEARCH ORGANIZATIONS 150
11.7 OTHERS 151

12 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL 152

12.1 OVERVIEW 153
12.2 RETAIL SALES 156
12.3 ONLINE SALES 156
12.4 DIRECT TENDER 157
12.5 OTHERS 158

13 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION 159

13.1 ASIA-PACIFIC 160
- 13.1.1 JAPAN 174
- 13.1.2 CHINA 182
- 13.1.3 SOUTH KOREA 190
- 13.1.4 INDIA 198
- 13.1.5 SINGAPORE 206
- 13.1.6 THAILAND 214
- 13.1.7 INDONESIA 223
- 13.1.8 MALAYSIA 231
- 13.1.9 PHILIPPINES 239
- 13.1.10 AUSTRALIA 247
- 13.1.11 NEW ZEALAND 255
- 13.1.12 VIETNAM 263
- 13.1.13 TAIWAN 271
- 13.1.14 REST OF ASIA-PACIFIC 279

14 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, COMPANY LANDSCAPE 280

14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 280

15 SWOT ANALYSIS 281

16 COMPANY PROFILE 282

16.1 MERCK KGAA 282
- 16.1.1 COMPANY SNAPSHOT 282
- 16.1.2 REVENUE ANALYSIS 282
- 16.1.3 COMPANY SHARE ANALYSIS 283
- 16.1.4 PRODUCT PORTFOLIO 283
- 16.1.5 RECENT DEVELOPMENT 283
16.2 ABBOTT 284
- 16.2.1 COMPANY SNAPSHOT 284
- 16.2.2 REVENUE ANALYSIS 284
- 16.2.3 COMPANY SHARE ANALYSIS 285
- 16.2.4 PRODUCT PORTFOLIO 285
- 16.2.5 RECENT DEVELOPMENT 286
16.3 AGILENT TECHNOLOGIES, INC. 287
- 16.3.1 COMPANY SNAPSHOT 287
- 16.3.2 REVENUE ANALYSIS 287
- 16.3.3 COMPANY SHARE ANALYSIS 288
- 16.3.4 PRODUCT PORTFOLIO 288
- 16.3.5 RECENT DEVELOPMENT 288
16.4 F. HOFFMANN-LA ROCHE LTD. 289
- 16.4.1 COMPANY SNAPSHOT 289
- 16.4.2 REVENUE ANALYSIS 289
- 16.4.3 COMPANY SHARE ANALYSIS 290
- 16.4.4 PRODUCT PORTFOLIO 290
- 16.4.5 RECENT DEVELOPMENT 290
16.5 THERMO FISCHER SCIENTIFIC INC. 291
- 16.5.1 COMPANY SNAPSHOT 291
- 16.5.2 REVENUE ANALYSIS 291
- 16.5.3 COMPANY SHARE ANALYSIS 292
- 16.5.4 PRODUCT PORTFOLIO 292
- 16.5.5 RECENT DEVELOPMENT 293
16.6 ABCAM PLC. 294
- 16.6.1 COMPANY SNAPSHOT 294
- 16.6.2 REVENUE ANALYSIS 294
- 16.6.3 COMPANY SHARE ANALYSIS 295
- 16.6.4 PRODUCT PORTFOLIO 295
- 16.6.5 RECENT DEVELOPMENTS 295
16.7 ABNOVA CORPORATION 297
- 16.7.1 COMPANY SNAPSHOT 297
- 16.7.2 PRODUCT PORTFOLIO 297
- 16.7.3 RECENT DEVELOPMENT 297
16.8 BIO SB 298
- 16.8.1 COMPANY SNAPSHOT 298
- 16.8.2 PRODUCT PORTFOLIO 298
- 16.8.3 RECENT DEVELOPMENT 298
16.9 BIOCARE MEDICAL, LLC 299
- 16.9.1 COMPANY SNAPSHOT 299
- 16.9.2 PRODUCT PORTFOLIO 299
- 16.9.3 RECENT DEVELOPMENT 300
16.10 BIOCAT GMBH 301
- 16.10.1 COMPANY SNAPSHOT 301
- 16.10.2 PRODUCT PORTFOLIO 301
- 16.10.3 RECENT DEVELOPMENT 302
16.11 BIODOT 303
- 16.11.1 COMPANY SNAPSHOT 303
- 16.11.2 PRODUCT PORTFOLIO 303
- 16.11.3 RECENT DEVELOPMENT 303
16.12 BIOGENEX 304
- 16.12.1 COMPANY SNAPSHOT 304
- 16.12.2 PRODUCT PORTFOLIO 304
- 16.12.3 RECENT DEVELOPMENT 304
16.13 BIO-TECHNE 305
- 16.13.1 COMPANY SNAPSHOT 305
- 16.13.2 REVENUE ANALYSIS 305
- 16.13.3 COMPANY SHARE ANALYSIS 306
- 16.13.4 PRODUCT PORTFOLIO 306
- 16.13.5 RECENT DEVELOPMENT 306
16.14 BIOZOL DIAGNOSTICS VERTRIEB GMBH 307
- 16.14.1 COMPANY SNAPSHOT 307
- 16.14.2 PRODUCT PORTFOLIO 307
- 16.14.3 RECENT DEVELOPMENT 308
16.15 EXCILONE 309
- 16.15.1 COMPANY SNAPSHOT 309
- 16.15.2 PRODUCT PORTFOLIO 309
- 16.15.3 RECENT DEVELOPMENT 309
16.16 GENEMED BIOTECHNOLOGIES, INC. 310
- 16.16.1 COMPANY SNAPSHOT 310
- 16.16.2 PRODUCT PORTFOLIO 310
- 16.16.3 RECENT DEVELOPMENT 310
16.17 KANEKA EUROGENTEC S.A. 311
- 16.17.1 COMPANY SNAPSHOT 311
- 16.17.2 PRODUCT PORTFOLIO 311
- 16.17.3 RECENT DEVELOPMENT 311
16.18 LEICA BIOSYSTEMS NUSSLOCH GMBH 312
- 16.18.1 COMPANY SNAPSHOT 312
- 16.18.2 PRODUCT PORTFOLIO 312
- 16.18.3 RECENT DEVELOPMENT 312
16.19 METASYSTEMS 313
- 16.19.1 COMPANY SNAPSHOT 313
- 16.19.2 PRODUCT PORTFOLIO 313
- 16.19.3 RECENT DEVELOPMENT 313

16.20 SYSMEX ASIA PACIFIC PTE LTD (A SUBSIDIARY OF SYSMEX CORPORATION) 314
- 16.20.1 COMPANY SNAPSHOT 314
- 16.20.2 REVENUE ANALYSIS 314
- 16.20.3 PRODUCT PORTFOLIO 315
- 16.20.4 RECENT DEVELOPMENT 315
16.21 ZYTOMED SYSTEMS GMBH 316
- 16.21.1 COMPANY SNAPSHOT 316
- 16.21.2 PRODUCT PORTFOLIO 316
- 16.21.3 RECENT DEVELOPMENT 316

17 QUESTIONNAIRE 317

18 RELATED REPORTS 321

LIST OF TABLES

TABLE 1 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 73
TABLE 2 ASIA PACIFIC CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 74
TABLE 3 ASIA PACIFIC CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 74
TABLE 4 ASIA PACIFIC FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 75
TABLE 5 ASIA PACIFIC FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 76
TABLE 6 ASIA PACIFIC FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 77
TABLE 7 ASIA PACIFIC RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 77
TABLE 8 ASIA PACIFIC ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 78
TABLE 9 ASIA PACIFIC INSTRUMENT IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 10 ASIA PACIFIC INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 79
TABLE 11 ASIA PACIFIC SOFTWARE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 80
TABLE 12 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 84
TABLE 13 ASIA PACIFIC RNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 85
TABLE 14 ASIA PACIFIC DNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 86
TABLE 15 ASIA PACIFIC PNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 16 ASIA PACIFIC OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 17 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 92
TABLE 18 ASIA PACIFIC CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 93
TABLE 19 ASIA PACIFIC CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 94
TABLE 20 ASIA PACIFIC NON-HEMATOPOETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 94
TABLE 21 ASIA PACIFIC HEMATOPOETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 95
TABLE 22 ASIA PACIFIC CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 96
TABLE 23 ASIA PACIFIC GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 24 ASIA PACIFIC GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 97
TABLE 25 ASIA PACIFIC INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 26 ASIA PACIFIC INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 99
TABLE 27 ASIA PACIFIC PERSONALIZED MEDICINE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 100
TABLE 28 ASIA PACIFIC OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 100
TABLE 29 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 104
TABLE 30 ASIA PACIFIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 105
TABLE 31 ASIA PACIFIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 105
TABLE 32 ASIA PACIFIC CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 106
TABLE 33 ASIA PACIFIC CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 107
TABLE 34 ASIA PACIFIC COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 108
TABLE 35 ASIA PACIFIC COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 108
TABLE 36 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 112
TABLE 37 ASIA PACIFIC DIAGNOSTIC LABORATORIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 113
TABLE 38 ASIA PACIFIC HOSPITALS & CLINICS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 114
TABLE 39 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 114
TABLE 40 ASIA PACIFIC ACADEMIC & RESEARCH INSTITUTES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 115
TABLE 41 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 116
TABLE 42 ASIA PACIFIC OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 116
TABLE 43 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 120
TABLE 44 ASIA PACIFIC RETAIL SALES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 121
TABLE 45 ASIA PACIFIC ONLINE SALES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 122
TABLE 46 ASIA PACIFIC DIRECT TENDER IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 122
TABLE 47 ASIA PACIFIC OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 123
TABLE 48 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 130
TABLE 49 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 50 ASIA-PACIFIC CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 51 ASIA-PACIFIC FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 131
TABLE 52 ASIA-PACIFIC FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 132
TABLE 53 ASIA-PACIFIC FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
TABLE 54 ASIA-PACIFIC RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 55 ASIA-PACIFIC ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 56 ASIA-PACIFIC INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 57 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 133
TABLE 58 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
TABLE 59 ASIA-PACIFIC CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 134
TABLE 60 ASIA-PACIFIC NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
TABLE 61 ASIA-PACIFIC HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
TABLE 62 ASIA-PACIFIC CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135
TABLE 63 ASIA-PACIFIC GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
TABLE 64 ASIA-PACIFIC INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
TABLE 65 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 136
TABLE 66 ASIA-PACIFIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 137
TABLE 67 ASIA-PACIFIC CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 137
TABLE 68 ASIA-PACIFIC COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 137
TABLE 69 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 138
TABLE 70 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 138
TABLE 71 JAPAN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 72 JAPAN CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 73 JAPAN FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 140
TABLE 74 JAPAN FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 140
TABLE 75 JAPAN FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 141
TABLE 76 JAPAN RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 77 JAPAN ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 78 JAPAN INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 79 JAPAN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 142
TABLE 80 JAPAN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 142
TABLE 81 JAPAN CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 143
TABLE 82 JAPAN NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 143
TABLE 83 JAPAN HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 143
TABLE 84 JAPAN CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 144
TABLE 85 JAPAN GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
TABLE 86 JAPAN INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
TABLE 87 JAPAN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 145
TABLE 88 JAPAN RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 145
TABLE 89 JAPAN CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 145
TABLE 90 JAPAN COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 146
TABLE 91 JAPAN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 146
TABLE 92 JAPAN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 146
TABLE 93 CHINA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 94 CHINA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 95 CHINA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 148
TABLE 96 CHINA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 148
TABLE 97 CHINA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 149
TABLE 98 CHINA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 99 CHINA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 100 CHINA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 101 CHINA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 150
TABLE 102 CHINA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 150
TABLE 103 CHINA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 151
TABLE 104 CHINA NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 151
TABLE 105 CHINA HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 151
TABLE 106 CHINA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 152
TABLE 107 CHINA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 152
TABLE 108 CHINA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 152
TABLE 109 CHINA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 153
TABLE 110 CHINA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 153
TABLE 111 CHINA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 153
TABLE 112 CHINA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 154
TABLE 113 CHINA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 154
TABLE 114 CHINA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 154
TABLE 115 SOUTH KOREA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 116 SOUTH KOREA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 117 SOUTH KOREA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 156
TABLE 118 SOUTH KOREA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 156
TABLE 119 SOUTH KOREA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 157
TABLE 120 SOUTH KOREA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
TABLE 121 SOUTH KOREA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
TABLE 122 SOUTH KOREA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
TABLE 123 SOUTH KOREA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 158
TABLE 124 SOUTH KOREA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 158
TABLE 125 SOUTH KOREA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 159
TABLE 126 SOUTH KOREA NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
TABLE 127 SOUTH KOREA HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
TABLE 128 SOUTH KOREA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 160
TABLE 129 SOUTH KOREA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
TABLE 130 SOUTH KOREA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
TABLE 131 SOUTH KOREA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 161
TABLE 132 SOUTH KOREA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 161
TABLE 133 SOUTH KOREA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 161
TABLE 134 SOUTH KOREA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 162
TABLE 135 SOUTH KOREA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 162
TABLE 136 SOUTH KOREA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 162

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SEGMENTATION 38
FIGURE 2 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DATA TRIANGULATION 41
FIGURE 3 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DROC ANALYSIS 42
FIGURE 4 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 43
FIGURE 5 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY RESEARCH ANALYSIS 43
FIGURE 6 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: INTERVIEW DEMOGRAPHICS 44
FIGURE 7 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: MARKET APPLICATION COVERAGE GRID 46
FIGURE 8 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DBMR MARKET POSITION GRID 48
FIGURE 9 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: VENDOR SHARE ANALYSIS 50
FIGURE 10 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SEGMENTATION 54
FIGURE 11 THE GROWING BURDEN OF GENETIC DISORDERS AS WELL AS CANCER AND HIGH FUNDING FOR RESEARCH ACTIVITIES IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET FROM 2023 TO 2030 55
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET IN 2023 AND 2030 55
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET 63
FIGURE 14 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, 2022 70
FIGURE 15 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 71
FIGURE 16 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 71
FIGURE 17 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, LIFELINE CURVE 72
FIGURE 18 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, 2022 81
FIGURE 19 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION) 82
FIGURE 20 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, CAGR (2023-2030) 82
FIGURE 21 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, LIFELINE CURVE 83
FIGURE 22 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, 2022 89
FIGURE 23 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 90
FIGURE 24 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, CAGR (2023-2030) 90
FIGURE 25 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, LIFELINE CURVE 91
FIGURE 26 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, 2022 101
FIGURE 27 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, 2023-2030 (USD MILLION) 102
FIGURE 28 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, CAGR (2023-2030) 102
FIGURE 29 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, LIFELINE CURVE 103
FIGURE 30 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, 2022 109
FIGURE 31 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, 2023-2030 (USD MILLION) 110
FIGURE 32 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, CAGR (2023-2030) 110
FIGURE 33 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, LIFELINE CURVE 111
FIGURE 34 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, 2022 117
FIGURE 35 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 118
FIGURE 36 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 118
FIGURE 37 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 119
FIGURE 38 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 125
FIGURE 39 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 126
FIGURE 40 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 126
FIGURE 41 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 127
FIGURE 42 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 128
FIGURE 43 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 244